Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Mar 29, 2023
- Accession no.
- 0001209191-23-021564
- Filed
- Mar 29, 2023
- Trade date
- Mar 27-29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $217.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +8,048 | $0.61 | +$4,909.28 | 536,029 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −8,048 | $16.00 | −$128,768 | 527,981 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseAcquired | +3,346 | $0.61 | +$2,041.06 | 531,327 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −3,346 | $16.00 | −$53,536 | 527,981 | Direct | |
| Mar 29, 2023 | Common Stock | MOption exerciseAcquired | +2,187 | $0.61 | +$1,334.07 | 530,168 | Direct | |
| Mar 29, 2023 | Common Stock | SSaleDisposed | −2,187 | $16.21 | −$35,451.27 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −8,048 | $0.00 | $0 | 239,354 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −3,346 | $0.00 | $0 | 236,008 | Direct | |
| Mar 29, 2023 | Common Stock | MOption exerciseDisposed | −2,187 | $0.00 | $0 | 233,821 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.